fda warning letter hims compounded semaglutide september 2025 Issues 30 Letters to Telehealth Firms Over Misleading GLP-1 Marketing Hims is in the crosshairs.

Bill, C

The Canadian Obesity Network provides resources for patients seeking obesity care, including a directory of physicians and clinics specializing in weight management across the country

Divide the dose already prescribed in mg by the pharmacy-label concentration in mg/mL

Actuaries at large benefits consultancies have been warning corporate boards since 2024 that GLP-1s could reshape health-plan budgets the way specialty oncology drugs did a decade earlier

Nurse-pharmacist collaborations for promoting medication safety among community-dwelling adults: A scoping review

Once a sterile container has been accessed, laboratories typically implement additional handling and documentation procedures